Micronization for Inhalation API Formulations

Why Particle Size is Critical in Inhalation Drugs

Inhalable APIs require particle sizes between 1–5 µm to ensure deep lung deposition and effective drug delivery. Uniformity is key for consistent dosing.

Microchem’s Expertise in Inhalation Processing

We use spiral jet mills and perform in-depth PSD control to optimize MMAD for dry powder inhalers (DPIs) and nebulized formulations.

Analytical and Documentation Support

We provide full analytical data sets, validation reports, and GMP-compliant batch records to support formulation and regulatory filings.

Improve your inhalation product performance with Microchem.